ID   NOS3_HUMAN              Reviewed;        1203 AA.
AC   P29474; A0S0A7; A0S0A8; A8KA63; B2RCQ1; E9PFR2; Q13662; Q14251;
AC   Q14434; Q548C1; Q6GSL5; Q9UDC6;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 207.
DE   RecName: Full=Nitric oxide synthase, endothelial;
DE            EC=1.14.13.39;
DE   AltName: Full=Constitutive NOS;
DE            Short=cNOS;
DE   AltName: Full=EC-NOS;
DE   AltName: Full=Endothelial NOS;
DE            Short=eNOS;
DE   AltName: Full=NOS type III;
DE            Short=NOSIII;
GN   Name=NOS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1378832;
RA   Janssens S.P., Shimouchi A., Quertermous T., Bloch D.B., Bloch K.D.;
RT   "Cloning and expression of a cDNA encoding human endothelium-derived
RT   relaxing factor/nitric oxide synthase.";
RL   J. Biol. Chem. 267:14519-14522(1992).
RN   [2]
RP   ERRATUM.
RA   Janssens S.P., Shimouchi A., Quertermous T., Bloch D.B., Bloch K.D.;
RL   J. Biol. Chem. 267:22694-22694(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1379542; DOI=10.1016/0014-5793(92)80697-F;
RA   Marsden P.A., Schappert K.T., Chen H.S., Flowers M., Sundell C.L.,
RA   Wilcox J.N., Lamas S., Michel T.;
RT   "Molecular cloning and characterization of human endothelial nitric
RT   oxide synthase.";
RL   FEBS Lett. 307:287-293(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7688726;
RA   Marsden P.A., Heng H.H.Q., Scherer S.W., Stewart R.J., Hall A.V.,
RA   Shi X.-M., Tsui L.-C., Schappert K.T.;
RT   "Structure and chromosomal localization of the human constitutive
RT   endothelial nitric oxide synthase gene.";
RL   J. Biol. Chem. 268:17478-17488(1993).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=7509596; DOI=10.1006/bbrc.1994.1146;
RA   Nadaud S.A., Bonnardeaux A., Lathrop M., Soubrier F.;
RT   "Gene structure, polymorphism and mapping of the human endothelial
RT   nitric oxide synthase gene.";
RL   Biochem. Biophys. Res. Commun. 198:1027-1033(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7519987; DOI=10.1111/j.1432-1033.1994.tb19045.x;
RA   Miyahara K., Kawamoto T., Sase K., Yui Y., Toda K., Yang L.X.,
RA   Hattori R., Aoyama T., Yamamoto Y., Doi Y., Ogoshi S., Hashimoto K.,
RA   Kawai C., Sasayama S., Shizuta Y.;
RT   "Cloning and structural characterization of the human endothelial
RT   nitric-oxide-synthase gene.";
RL   Eur. J. Biochem. 223:719-726(1994).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ENOS13B AND ENOS13C), ALTERNATIVE
RP   SPLICING, FUNCTION (ISOFORM ENOS13C), AND VARIANT ASP-298.
RX   PubMed=17264164; DOI=10.1096/fj.06-7434com;
RA   Lorenz M., Hewing B., Hui J., Zepp A., Baumann G., Bindereif A.,
RA   Stangl V., Stangl K.;
RT   "Alternative splicing in intron 13 of the human eNOS gene: a potential
RT   mechanism for regulating eNOS activity.";
RL   FASEB J. 21:1556-1564(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Umbilical vein;
RA   Liao J.K.;
RL   Submitted (DEC-1993) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Platelet;
RA   Zhang Y., Freedman J.E.;
RT   "The role of phosphatidylinositol-3-oh kinase in platelet-derived
RT   nitric oxide release and platelet disaggregation.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASP-298.
RC   TISSUE=Hippocampus, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Spleen;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLN-112; ASP-298;
RP   MET-827; MET-885 AND LEU-982.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASP-298.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-53.
RC   TISSUE=Placenta;
RX   PubMed=7514568; DOI=10.1006/geno.1994.1068;
RA   Robinson L.J., Weremowicz S., Morton C.C., Michel T.;
RT   "Isolation and chromosomal localization of the human endothelial
RT   nitric oxide synthase (NOS3) gene.";
RL   Genomics 19:350-357(1994).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 411-528 (ISOFORM 1/ENOS13C).
RC   TISSUE=Platelet;
RX   PubMed=7475956; DOI=10.1016/0024-3205(95)02191-K;
RA   Sase K., Michel T.;
RT   "Expression of constitutive endothelial nitric oxide synthase in human
RT   blood platelets.";
RL   Life Sci. 57:2049-2055(1995).
RN   [19]
RP   PROTEIN SEQUENCE OF 167-175; 531-540; 835-845; 876-881; 886-898;
RP   1001-1005 AND 1068-1080, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   PubMed=7515611; DOI=10.1006/abbi.1994.1232;
RA   Garvey E.P., Tuttle J.V., Covington K., Merrill B.M., Wood E.R.,
RA   Baylis S.A., Charles I.G.;
RT   "Purification and characterization of the constitutive nitric oxide
RT   synthase from human placenta.";
RL   Arch. Biochem. Biophys. 311:235-241(1994).
RN   [20]
RP   INTERACTION WITH NOSIP, ENZYME REGULATION, AND SUBCELLULAR LOCATION.
RX   PubMed=11149895; DOI=10.1096/fj.00-0078com;
RA   Dedio J., Koenig P., Wohlfart P., Schroeder C., Kummer W.,
RA   Mueller-Esterl W.;
RT   "NOSIP, a novel modulator of endothelial nitric oxide synthase
RT   activity.";
RL   FASEB J. 15:79-89(2001).
RN   [21]
RP   INTERACTION WITH NOSTRIN, ENZYME REGULATION, AND SUBCELLULAR LOCATION.
RX   PubMed=12446846; DOI=10.1073/pnas.252345399;
RA   Zimmermann K., Opitz N., Dedio J., Renne C., Mueller-Esterl W.,
RA   Oess S.;
RT   "NOSTRIN: a protein modulating nitric oxide release and subcellular
RT   distribution of endothelial nitric oxide synthase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:17167-17172(2002).
RN   [22]
RP   PHOSPHORYLATION AT THR-495 AND SER-1177.
RX   PubMed=16126727; DOI=10.1074/jbc.M506374200;
RA   David-Dufilho M., Millanvoye-Van Brussel E., Topal G., Walch L.,
RA   Brunet A., Rendu F.;
RT   "Endothelial thrombomodulin induces Ca2+ signals and nitric oxide
RT   synthesis through epidermal growth factor receptor kinase and
RT   calmodulin kinase II.";
RL   J. Biol. Chem. 280:35999-36006(2005).
RN   [23]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16234328; DOI=10.1242/jcs.02620;
RA   Icking A., Matt S., Opitz N., Wiesenthal A., Mueller-Esterl W.,
RA   Schilling K.;
RT   "NOSTRIN functions as a homotrimeric adaptor protein facilitating
RT   internalization of eNOS.";
RL   J. Cell Sci. 118:5059-5069(2005).
RN   [24]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16135813; DOI=10.1128/MCB.25.18.8251-8258.2005;
RA   Schleicher M., Brundin F., Gross S., Mueller-Esterl W., Oess S.;
RT   "Cell cycle-regulated inactivation of endothelial NO synthase through
RT   NOSIP-dependent targeting to the cytoskeleton.";
RL   Mol. Cell. Biol. 25:8251-8258(2005).
RN   [25]
RP   PHOSPHORYLATION AT SER-114, AND MUTAGENESIS OF SER-114.
RX   PubMed=20213743; DOI=10.1002/jcb.22515;
RA   Lee C.-H., Wei Y.-W., Huang Y.-T., Lin Y.-T., Lee Y.-C., Lee K.-H.,
RA   Lu P.-J.;
RT   "CDK5 phosphorylates eNOS at Ser-113 and regulates NO production.";
RL   J. Cell. Biochem. 110:112-117(2010).
RN   [26]
RP   INTERACTION WITH HSP90AB1.
RX   PubMed=23585225; DOI=10.1152/ajplung.00419.2012;
RA   Barabutis N., Handa V., Dimitropoulou C., Rafikov R., Snead C.,
RA   Kumar S., Joshi A., Thangjam G., Fulton D., Black S.M., Patel V.,
RA   Catravas J.D.;
RT   "LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in
RT   lung vascular endothelial cells and mouse lung.";
RL   Am. J. Physiol. 304:L883-L893(2013).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1177, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-33; SER-633; SER-638 AND
RP   SER-836, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS).
RX   PubMed=10074942; DOI=10.1038/6675;
RA   Fischmann T.O., Hruza A., Niu X.D., Fossetta J.D., Lunn C.A.,
RA   Dolphin E., Prongay A.J., Reichert P., Lundell D.J., Narula S.K.,
RA   Weber P.C.;
RT   "Structural characterization of nitric oxide synthase isoforms reveals
RT   striking active-site conservation.";
RL   Nat. Struct. Biol. 6:233-242(1999).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS) OF 67-480.
RX   PubMed=12437348; DOI=10.1021/bi026313j;
RA   Rosenfeld R.J., Garcin E.D., Panda K., Andersson G., Aberg A.,
RA   Wallace A.V., Morris G.M., Olson A.J., Stuehr D.J., Tainer J.A.,
RA   Getzoff E.D.;
RT   "Conformational changes in nitric oxide synthases induced by
RT   chlorzoxazone and nitroindazoles: crystallographic and computational
RT   analyses of inhibitor potency.";
RL   Biochemistry 41:13915-13925(2002).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.44 ANGSTROMS) OF 66-492.
RX   PubMed=18849972; DOI=10.1038/nchembio.115;
RA   Garcin E.D., Arvai A.S., Rosenfeld R.J., Kroeger M.D., Crane B.R.,
RA   Andersson G., Andrews G., Hamley P.J., Mallinder P.R., Nicholls D.J.,
RA   St-Gallay S.A., Tinker A.C., Gensmantel N.P., Mete A., Cheshire D.R.,
RA   Connolly S., Stuehr D.J., Aberg A., Wallace A.V., Tainer J.A.,
RA   Getzoff E.D.;
RT   "Anchored plasticity opens doors for selective inhibitor design in
RT   nitric oxide synthase.";
RL   Nat. Chem. Biol. 4:700-707(2008).
RN   [32]
RP   VARIANT ASP-298, AND POSSIBLE INVOLVEMENT IN SUSCEPTIBILITY TO
RP   CORONARY SPASM.
RX   PubMed=9737779; DOI=10.1007/s004390050785;
RA   Yoshimura M., Yasue H., Nakayama M., Shimasaki Y., Sumida H.,
RA   Sugiyama S., Kugiyama K., Ogawa H., Ogawa Y., Saito Y., Miyamoto Y.,
RA   Nakao K.;
RT   "A missense Glu298Asp variant in the endothelial nitric oxide synthase
RT   gene is associated with coronary spasm in the Japanese.";
RL   Hum. Genet. 103:65-69(1998).
RN   [33]
RP   VARIANT ASP-298, AND POSSIBLE INVOLVEMENT IN SUSCEPTIBILITY TO
RP   CORONARY SPASM.
RX   PubMed=11740345; DOI=10.1097/00008571-200112000-00009;
RA   Sofowora G., Dishy V., Xie H.G., Imamura H., Nishimi Y., Morales C.R.,
RA   Morrow J.D., Kim R.B., Stein C.M., Wood A.J.;
RT   "In-vivo effects of Glu298Asp endothelial nitric oxide synthase
RT   polymorphism.";
RL   Pharmacogenetics 11:809-814(2001).
RN   [34]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-474 AND GLN-602.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Produces nitric oxide (NO) which is implicated in
CC       vascular smooth muscle relaxation through a cGMP-mediated signal
CC       transduction pathway. NO mediates vascular endothelial growth
CC       factor (VEGF)-induced angiogenesis in coronary vessels and
CC       promotes blood clotting through the activation of platelets.
CC   -!- FUNCTION: Isoform eNOS13C: Lacks eNOS activity, dominant-negative
CC       form that may down-regulate eNOS activity by forming heterodimers
CC       with isoform 1.
CC   -!- CATALYTIC ACTIVITY: 2 L-arginine + 3 NADPH + 4 O(2) = 2 L-
CC       citrulline + 2 nitric oxide + 3 NADP(+) + 4 H(2)O.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD.;
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC       Note=Binds 1 FMN.;
CC   -!- COFACTOR:
CC       Name=(6R)-L-erythro-5,6,7,8-tetrahydrobiopterin;
CC         Xref=ChEBI:CHEBI:59560;
CC       Note=Tetrahydrobiopterin (BH4). May stabilize the dimeric form of
CC       the enzyme.;
CC   -!- ENZYME REGULATION: Stimulated by calcium/calmodulin. Inhibited by
CC       NOSIP and NOSTRIN. {ECO:0000269|PubMed:11149895,
CC       ECO:0000269|PubMed:12446846}.
CC   -!- SUBUNIT: Homodimer. Interacts with NOSIP and NOSTRIN. Interacts
CC       with HSP90AB1 (PubMed:23585225). {ECO:0000269|PubMed:11149895,
CC       ECO:0000269|PubMed:12446846, ECO:0000269|PubMed:23585225}.
CC   -!- INTERACTION:
CC       P31749:AKT1; NbExp=2; IntAct=EBI-1391623, EBI-296087;
CC       Q16543:CDC37; NbExp=4; IntAct=EBI-1391623, EBI-295634;
CC       P35222:CTNNB1; NbExp=4; IntAct=EBI-1391623, EBI-491549;
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-1391623, EBI-618309;
CC       P43364-2:MAGEA11; NbExp=3; IntAct=EBI-1391623, EBI-10178634;
CC       Q8IVI9:NOSTRIN; NbExp=9; IntAct=EBI-1391623, EBI-1391643;
CC       P50502:ST13; NbExp=3; IntAct=EBI-1391623, EBI-357285;
CC       P14079:tax (xeno); NbExp=3; IntAct=EBI-1391623, EBI-9675698;
CC   -!- SUBCELLULAR LOCATION: Cell membrane. Membrane, caveola. Cytoplasm,
CC       cytoskeleton. Golgi apparatus. Note=Specifically associates with
CC       actin cytoskeleton in the G2 phase of the cell cycle; which is
CC       favored by interaction with NOSIP and results in a reduced
CC       enzymatic activity.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P29474-1; Sequence=Displayed;
CC       Name=eNOS13C;
CC         IsoId=P29474-2; Sequence=VSP_042625, VSP_042626;
CC         Note=Lacks eNOS activity.;
CC       Name=eNOS13B;
CC         IsoId=P29474-3; Sequence=VSP_045495, VSP_045496;
CC   -!- TISSUE SPECIFICITY: Platelets, placenta, liver and kidney.
CC       {ECO:0000269|PubMed:7515611}.
CC   -!- PTM: Phosphorylation by AMPK at Ser-1177 in the presence of
CC       Ca(2+)-calmodulin (CaM) activates activity. In absence of Ca(2+)-
CC       calmodulin, AMPK also phosphorylates Thr-495, resulting in
CC       inhibition of activity (By similarity). Phosphorylation of Ser-114
CC       by CDK5 reduces activity. {ECO:0000250,
CC       ECO:0000269|PubMed:16126727, ECO:0000269|PubMed:20213743}.
CC   -!- DISEASE: Note=Variation in NOS3 seem to be associated with
CC       susceptibility to coronary spasm. {ECO:0000269|PubMed:11740345,
CC       ECO:0000269|PubMed:9737779}.
CC   -!- SIMILARITY: Belongs to the NOS family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Nitric oxide synthase entry;
CC       URL="https://en.wikipedia.org/wiki/Nitric_oxide_synthase";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/nos3/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M93718; AAA36364.1; -; mRNA.
DR   EMBL; M95296; AAA36372.1; -; mRNA.
DR   EMBL; L10709; AAA36365.1; -; Genomic_DNA.
DR   EMBL; L10693; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10694; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10695; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10696; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10697; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10698; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10699; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10700; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10701; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10702; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10703; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10704; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10705; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10706; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10707; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; L10708; AAA36365.1; JOINED; Genomic_DNA.
DR   EMBL; X76303; CAA53950.1; -; Genomic_DNA.
DR   EMBL; X76304; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76305; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76306; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76307; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76308; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76309; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76310; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76311; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76312; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76313; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76314; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76315; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; X76316; CAA53950.1; JOINED; Genomic_DNA.
DR   EMBL; D26607; BAA05652.1; -; Genomic_DNA.
DR   EMBL; DQ256130; ABB79839.1; -; mRNA.
DR   EMBL; DQ256131; ABB79840.1; -; mRNA.
DR   EMBL; L26914; AAA36374.1; -; Genomic_DNA.
DR   EMBL; AF400594; AAK83389.1; -; mRNA.
DR   EMBL; AK292928; BAF85617.1; -; mRNA.
DR   EMBL; AK315213; BAG37648.1; -; mRNA.
DR   EMBL; AK223636; BAD97356.1; -; mRNA.
DR   EMBL; AF519768; AAM74944.1; -; Genomic_DNA.
DR   EMBL; EU332855; ABY87544.1; -; Genomic_DNA.
DR   EMBL; AC010973; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471173; EAW54069.1; -; Genomic_DNA.
DR   EMBL; BC063294; AAH63294.1; -; mRNA.
DR   EMBL; BC069465; AAH69465.1; -; mRNA.
DR   EMBL; L23210; AAA36373.1; -; Genomic_DNA.
DR   EMBL; S80791; AAD14336.1; -; mRNA.
DR   CCDS; CCDS55182.1; -. [P29474-2]
DR   CCDS; CCDS55183.1; -. [P29474-3]
DR   CCDS; CCDS5912.1; -. [P29474-1]
DR   PIR; A47501; A47501.
DR   RefSeq; NP_000594.2; NM_000603.4.
DR   RefSeq; NP_001153581.1; NM_001160109.1.
DR   RefSeq; NP_001153582.1; NM_001160110.1.
DR   RefSeq; NP_001153583.1; NM_001160111.1.
DR   RefSeq; XP_016867721.1; XM_017012232.1.
DR   UniGene; Hs.647092; -.
DR   PDB; 1M9J; X-ray; 2.43 A; A/B=67-481.
DR   PDB; 1M9K; X-ray; 2.01 A; A/B=67-481.
DR   PDB; 1M9M; X-ray; 1.96 A; A/B=67-481.
DR   PDB; 1M9Q; X-ray; 2.01 A; A/B=67-481.
DR   PDB; 1M9R; X-ray; 2.56 A; A/B=67-481.
DR   PDB; 1NIW; X-ray; 2.05 A; B/D/F/H=492-511.
DR   PDB; 2LL7; NMR; -; B=493-509.
DR   PDB; 2MG5; NMR; -; B=495-510.
DR   PDB; 2N8J; NMR; -; B=491-512.
DR   PDB; 3EAH; X-ray; 2.44 A; A/B=66-492.
DR   PDB; 3NOS; X-ray; 2.40 A; A/B=66-492.
DR   PDB; 4D1O; X-ray; 1.82 A; A/B=41-480.
DR   PDB; 4D1P; X-ray; 1.73 A; A/B=41-480.
DR   PDBsum; 1M9J; -.
DR   PDBsum; 1M9K; -.
DR   PDBsum; 1M9M; -.
DR   PDBsum; 1M9Q; -.
DR   PDBsum; 1M9R; -.
DR   PDBsum; 1NIW; -.
DR   PDBsum; 2LL7; -.
DR   PDBsum; 2MG5; -.
DR   PDBsum; 2N8J; -.
DR   PDBsum; 3EAH; -.
DR   PDBsum; 3NOS; -.
DR   PDBsum; 4D1O; -.
DR   PDBsum; 4D1P; -.
DR   ProteinModelPortal; P29474; -.
DR   SMR; P29474; -.
DR   BioGrid; 110909; 46.
DR   DIP; DIP-38479N; -.
DR   IntAct; P29474; 34.
DR   MINT; MINT-106980; -.
DR   STRING; 9606.ENSP00000297494; -.
DR   BindingDB; P29474; -.
DR   ChEMBL; CHEMBL4803; -.
DR   DrugBank; DB02335; 2-Aminothiazoline.
DR   DrugBank; DB01997; 3-Bromo-7-Nitroindazole.
DR   DrugBank; DB04534; 5-Nitroindazole.
DR   DrugBank; DB03100; 6-Nitroindazole.
DR   DrugBank; DB02207; 7-Nitroindazole.
DR   DrugBank; DB03065; 7-Nitroindazole-2-Carboxamidine.
DR   DrugBank; DB05676; Apremilast.
DR   DrugBank; DB00997; Doxorubicin.
DR   DrugBank; DB07388; ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE.
DR   DrugBank; DB02234; Ethylisothiourea.
DR   DrugBank; DB02994; Hydroxydimethylarsine Oxide.
DR   DrugBank; DB01833; L-2-Amino-4-(Guanidinooxy)Butyric Acid.
DR   DrugBank; DB00125; L-Arginine.
DR   DrugBank; DB00155; L-Citrulline.
DR   DrugBank; DB03974; L-Homoarginine.
DR   DrugBank; DB02077; L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB02044; N-(3-(Aminomethyl)Benzyl)Acetamidine.
DR   DrugBank; DB04559; N-(Chlorophenyl)-N'-Hydroxyguanidine.
DR   DrugBank; DB03144; N-Omega-Hydroxy-L-Arginine.
DR   DrugBank; DB02027; N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine.
DR   DrugBank; DB03305; N5-Iminoethyl-L-Ornithine.
DR   DrugBank; DB04223; Nitroarginine.
DR   DrugBank; DB03963; S-(Dimethylarsenic)Cysteine.
DR   DrugBank; DB03707; S-Ethyl-N-Phenyl-Isothiourea.
DR   DrugBank; DB04018; S-Isopropyl-Isothiourea.
DR   DrugBank; DB00360; Sapropterin.
DR   DrugBank; DB02589; Se-Ethyl-Isoselenourea.
DR   GuidetoPHARMACOLOGY; 1249; -.
DR   iPTMnet; P29474; -.
DR   PhosphoSitePlus; P29474; -.
DR   SwissPalm; P29474; -.
DR   BioMuta; NOS3; -.
DR   DMDM; 266648; -.
DR   EPD; P29474; -.
DR   MaxQB; P29474; -.
DR   PaxDb; P29474; -.
DR   PeptideAtlas; P29474; -.
DR   PRIDE; P29474; -.
DR   DNASU; 4846; -.
DR   Ensembl; ENST00000297494; ENSP00000297494; ENSG00000164867.
DR   Ensembl; ENST00000484524; ENSP00000420215; ENSG00000164867.
DR   GeneID; 4846; -.
DR   KEGG; hsa:4846; -.
DR   UCSC; uc003wif.4; human. [P29474-1]
DR   CTD; 4846; -.
DR   DisGeNET; 4846; -.
DR   GeneCards; NOS3; -.
DR   H-InvDB; HIX0033558; -.
DR   HGNC; HGNC:7876; NOS3.
DR   HPA; CAB002168; -.
DR   MalaCards; NOS3; -.
DR   MIM; 163729; gene+phenotype.
DR   neXtProt; NX_P29474; -.
DR   PharmGKB; PA254; -.
DR   eggNOG; KOG1158; Eukaryota.
DR   eggNOG; COG0369; LUCA.
DR   eggNOG; COG4362; LUCA.
DR   HOGENOM; HOG000111088; -.
DR   HOVERGEN; HBG000159; -.
DR   InParanoid; P29474; -.
DR   KO; K13242; -.
DR   OrthoDB; EOG091G10Z0; -.
DR   PhylomeDB; P29474; -.
DR   TreeFam; TF324410; -.
DR   BioCyc; MetaCyc:HS09149-MONOMER; -.
DR   BRENDA; 1.14.13.39; 2681.
DR   Reactome; R-HSA-1222556; ROS, RNS production in phagocytes.
DR   Reactome; R-HSA-1474151; Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation.
DR   Reactome; R-HSA-203615; eNOS activation.
DR   Reactome; R-HSA-203641; NOSTRIN mediated eNOS trafficking.
DR   Reactome; R-HSA-203754; NOSIP mediated eNOS trafficking.
DR   Reactome; R-HSA-392154; Nitric oxide stimulates guanylate cyclase.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   SignaLink; P29474; -.
DR   SIGNOR; P29474; -.
DR   ChiTaRS; NOS3; human.
DR   EvolutionaryTrace; P29474; -.
DR   GeneWiki; Endothelial_NOS; -.
DR   GenomeRNAi; 4846; -.
DR   PRO; PR:P29474; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000164867; -.
DR   CleanEx; HS_NOS3; -.
DR   ExpressionAtlas; P29474; baseline and differential.
DR   Genevisible; P29474; HS.
DR   GO; GO:0005901; C:caveola; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISS:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0003785; F:actin monomer binding; IPI:BHF-UCL.
DR   GO; GO:0034618; F:arginine binding; IDA:BHF-UCL.
DR   GO; GO:0046870; F:cadmium ion binding; NAS:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; NAS:BHF-UCL.
DR   GO; GO:0010181; F:FMN binding; NAS:BHF-UCL.
DR   GO; GO:0020037; F:heme binding; IDA:BHF-UCL.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0050661; F:NADP binding; NAS:BHF-UCL.
DR   GO; GO:0003958; F:NADPH-hemoprotein reductase activity; IBA:GO_Central.
DR   GO; GO:0004517; F:nitric-oxide synthase activity; IDA:BHF-UCL.
DR   GO; GO:0097110; F:scaffold protein binding; IEA:Ensembl.
DR   GO; GO:0034617; F:tetrahydrobiopterin binding; IDA:BHF-UCL.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   GO; GO:0006527; P:arginine catabolic process; IDA:BHF-UCL.
DR   GO; GO:0001974; P:blood vessel remodeling; ISS:BHF-UCL.
DR   GO; GO:0045454; P:cell redox homeostasis; TAS:Reactome.
DR   GO; GO:0043542; P:endothelial cell migration; IMP:BHF-UCL.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0007005; P:mitochondrion organization; ISS:BHF-UCL.
DR   GO; GO:0045776; P:negative regulation of blood pressure; IBA:GO_Central.
DR   GO; GO:0051926; P:negative regulation of calcium ion transport; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; ISS:BHF-UCL.
DR   GO; GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; ISS:BHF-UCL.
DR   GO; GO:0051346; P:negative regulation of hydrolase activity; IEA:Ensembl.
DR   GO; GO:0014740; P:negative regulation of muscle hyperplasia; ISS:BHF-UCL.
DR   GO; GO:0010544; P:negative regulation of platelet activation; NAS:BHF-UCL.
DR   GO; GO:0043267; P:negative regulation of potassium ion transport; IEA:Ensembl.
DR   GO; GO:0006809; P:nitric oxide biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0007263; P:nitric oxide mediated signal transduction; IBA:GO_Central.
DR   GO; GO:0001542; P:ovulation from ovarian follicle; IEA:Ensembl.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISS:BHF-UCL.
DR   GO; GO:0031284; P:positive regulation of guanylate cyclase activity; IMP:BHF-UCL.
DR   GO; GO:0008217; P:regulation of blood pressure; NAS:BHF-UCL.
DR   GO; GO:0050880; P:regulation of blood vessel size; ISS:BHF-UCL.
DR   GO; GO:0050999; P:regulation of nitric-oxide synthase activity; TAS:Reactome.
DR   GO; GO:0002028; P:regulation of sodium ion transport; IEA:Ensembl.
DR   GO; GO:0003100; P:regulation of systemic arterial blood pressure by endothelin; IMP:BHF-UCL.
DR   GO; GO:0003057; P:regulation of the force of heart contraction by chemical signal; IEA:Ensembl.
DR   GO; GO:0019430; P:removal of superoxide radicals; IDA:BHF-UCL.
DR   GO; GO:0034405; P:response to fluid shear stress; IEP:BHF-UCL.
DR   GO; GO:0009408; P:response to heat; NAS:BHF-UCL.
DR   GO; GO:0014806; P:smooth muscle hyperplasia; ISS:BHF-UCL.
DR   GO; GO:0042311; P:vasodilation; NAS:BHF-UCL.
DR   Gene3D; 3.40.50.360; -; 1.
DR   InterPro; IPR003097; FAD-binding_1.
DR   InterPro; IPR017927; Fd_Rdtase_FAD-bd.
DR   InterPro; IPR001094; Flavdoxin-like.
DR   InterPro; IPR008254; Flavodoxin/NO_synth.
DR   InterPro; IPR001709; Flavoprot_Pyr_Nucl_cyt_Rdtase.
DR   InterPro; IPR029039; Flavoprotein-like_dom.
DR   InterPro; IPR012144; NOS_euk.
DR   InterPro; IPR004030; NOS_N.
DR   InterPro; IPR001433; OxRdtase_FAD/NAD-bd.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF00667; FAD_binding_1; 1.
DR   Pfam; PF00258; Flavodoxin_1; 1.
DR   Pfam; PF00175; NAD_binding_1; 1.
DR   Pfam; PF02898; NO_synthase; 1.
DR   PIRSF; PIRSF000333; NOS; 1.
DR   PRINTS; PR00369; FLAVODOXIN.
DR   PRINTS; PR00371; FPNCR.
DR   SUPFAM; SSF52218; SSF52218; 1.
DR   SUPFAM; SSF56512; SSF56512; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS51384; FAD_FR; 1.
DR   PROSITE; PS50902; FLAVODOXIN_LIKE; 1.
DR   PROSITE; PS60001; NOS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Calmodulin-binding;
KW   Cell membrane; Complete proteome; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; FAD; Flavoprotein; FMN; Golgi apparatus;
KW   Heme; Iron; Lipoprotein; Membrane; Metal-binding; Myristate; NADP;
KW   Oxidoreductase; Palmitate; Phosphoprotein; Polymorphism;
KW   Reference proteome; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P29473}.
FT   CHAIN         2   1203       Nitric oxide synthase, endothelial.
FT                                /FTId=PRO_0000170943.
FT   DOMAIN      520    703       Flavodoxin-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00088}.
FT   DOMAIN      756   1002       FAD-binding FR-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00716}.
FT   NP_BIND     649    680       FMN. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00088}.
FT   NP_BIND     793    804       FAD. {ECO:0000250}.
FT   NP_BIND     935    945       FAD. {ECO:0000250}.
FT   NP_BIND    1010   1028       NADP. {ECO:0000250}.
FT   NP_BIND    1108   1123       NADP. {ECO:0000250}.
FT   REGION       98    486       Interaction with NOSIP.
FT                                {ECO:0000269|PubMed:11149895}.
FT   REGION      491    510       Calmodulin-binding. {ECO:0000255}.
FT   METAL        94     94       Zinc.
FT   METAL        99     99       Zinc.
FT   METAL       184    184       Iron (heme axial ligand).
FT   MOD_RES      33     33       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     114    114       Phosphoserine; by CDK5.
FT                                {ECO:0000269|PubMed:20213743}.
FT   MOD_RES     495    495       Phosphothreonine; by AMPK.
FT                                {ECO:0000269|PubMed:16126727}.
FT   MOD_RES     615    615       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70313}.
FT   MOD_RES     633    633       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     638    638       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     836    836       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES    1175   1175       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P70313}.
FT   MOD_RES    1177   1177       Phosphoserine; by AMPK.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:16126727}.
FT   MOD_RES    1179   1179       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P70313}.
FT   LIPID         2      2       N-myristoyl glycine. {ECO:0000250}.
FT   LIPID        15     15       S-palmitoyl cysteine. {ECO:0000250}.
FT   LIPID        26     26       S-palmitoyl cysteine. {ECO:0000250}.
FT   VAR_SEQ     584    625       ESFAAALMEMSGPYNSSPRPEQHKSYKIRFNSISCSDPLVS
FT                                S -> EGLTLWPRLECSSTITAHCSLNLLDSSNPPTSTSQV
FT                                VGTTGACHDA (in isoform eNOS13C).
FT                                {ECO:0000303|PubMed:17264164}.
FT                                /FTId=VSP_042625.
FT   VAR_SEQ     585    614       SFAAALMEMSGPYNSSPRPEQHKSYKIRFN -> RWGFAML
FT                                PRLVSNSWVQAIHLPRPPKVLRL (in isoform
FT                                eNOS13B). {ECO:0000303|PubMed:17264164}.
FT                                /FTId=VSP_045495.
FT   VAR_SEQ     615   1203       Missing (in isoform eNOS13B).
FT                                {ECO:0000303|PubMed:17264164}.
FT                                /FTId=VSP_045496.
FT   VAR_SEQ     626   1203       Missing (in isoform eNOS13C).
FT                                {ECO:0000303|PubMed:17264164}.
FT                                /FTId=VSP_042626.
FT   VARIANT     112    112       R -> Q (in dbSNP:rs3918166).
FT                                {ECO:0000269|Ref.12}.
FT                                /FTId=VAR_031218.
FT   VARIANT     298    298       E -> D (polymorphism; may be associated
FT                                with susceptibility to coronary spasm;
FT                                dbSNP:rs1799983).
FT                                {ECO:0000269|PubMed:11740345,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17264164,
FT                                ECO:0000269|PubMed:9737779,
FT                                ECO:0000269|Ref.12}.
FT                                /FTId=VAR_008037.
FT   VARIANT     474    474       R -> C (found in a colorectal cancer
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036303.
FT   VARIANT     602    602       R -> Q (found in a colorectal cancer
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036304.
FT   VARIANT     665    665       R -> H (in dbSNP:rs7792133).
FT                                /FTId=VAR_061377.
FT   VARIANT     827    827       V -> M (in dbSNP:rs3918232).
FT                                {ECO:0000269|Ref.12}.
FT                                /FTId=VAR_031219.
FT   VARIANT     885    885       R -> M (in dbSNP:rs3918201).
FT                                {ECO:0000269|Ref.12}.
FT                                /FTId=VAR_031220.
FT   VARIANT     982    982       Q -> L (in dbSNP:rs3918234).
FT                                {ECO:0000269|Ref.12}.
FT                                /FTId=VAR_031221.
FT   MUTAGEN     114    114       S->A: Reduced nitrite (NO) production.
FT                                {ECO:0000269|PubMed:20213743}.
FT   CONFLICT     53     53       S -> R (in Ref. 17; AAA36373).
FT                                {ECO:0000305}.
FT   CONFLICT    168    168       S -> G (in Ref. 10; BAG37648).
FT                                {ECO:0000305}.
FT   CONFLICT    414    414       K -> R (in Ref. 10; BAF85617).
FT                                {ECO:0000305}.
FT   CONFLICT    489    489       G -> S (in Ref. 18; AAD14336).
FT                                {ECO:0000305}.
FT   CONFLICT    567    567       V -> W (in Ref. 5; CAA53950).
FT                                {ECO:0000305}.
FT   CONFLICT   1150   1150       R -> RQ (in Ref. 6; BAA05652).
FT                                {ECO:0000305}.
FT   CONFLICT   1194   1194       D -> E (in Ref. 5; CAA53950).
FT                                {ECO:0000305}.
FT   STRAND       70     73       {ECO:0000244|PDB:4D1P}.
FT   TURN         74     76       {ECO:0000244|PDB:4D1P}.
FT   STRAND       79     81       {ECO:0000244|PDB:4D1P}.
FT   HELIX        84     87       {ECO:0000244|PDB:4D1P}.
FT   STRAND       88     90       {ECO:0000244|PDB:3NOS}.
FT   HELIX       120    137       {ECO:0000244|PDB:4D1P}.
FT   HELIX       144    160       {ECO:0000244|PDB:4D1P}.
FT   HELIX       167    179       {ECO:0000244|PDB:4D1P}.
FT   HELIX       187    189       {ECO:0000244|PDB:4D1P}.
FT   STRAND      194    197       {ECO:0000244|PDB:4D1P}.
FT   HELIX       204    219       {ECO:0000244|PDB:4D1P}.
FT   HELIX       220    222       {ECO:0000244|PDB:4D1P}.
FT   STRAND      227    230       {ECO:0000244|PDB:4D1P}.
FT   STRAND      236    238       {ECO:0000244|PDB:1M9K}.
FT   STRAND      245    249       {ECO:0000244|PDB:4D1P}.
FT   STRAND      253    255       {ECO:0000244|PDB:4D1P}.
FT   STRAND      261    263       {ECO:0000244|PDB:4D1P}.
FT   HELIX       265    267       {ECO:0000244|PDB:4D1P}.
FT   HELIX       268    276       {ECO:0000244|PDB:4D1P}.
FT   STRAND      284    286       {ECO:0000244|PDB:4D1P}.
FT   STRAND      291    294       {ECO:0000244|PDB:4D1P}.
FT   STRAND      301    303       {ECO:0000244|PDB:4D1P}.
FT   HELIX       307    309       {ECO:0000244|PDB:4D1P}.
FT   STRAND      312    314       {ECO:0000244|PDB:4D1P}.
FT   HELIX       323    326       {ECO:0000244|PDB:4D1P}.
FT   STRAND      329    332       {ECO:0000244|PDB:4D1P}.
FT   STRAND      340    343       {ECO:0000244|PDB:4D1P}.
FT   STRAND      346    349       {ECO:0000244|PDB:4D1P}.
FT   HELIX       359    363       {ECO:0000244|PDB:4D1P}.
FT   HELIX       365    368       {ECO:0000244|PDB:4D1P}.
FT   TURN        370    373       {ECO:0000244|PDB:4D1P}.
FT   HELIX       376    382       {ECO:0000244|PDB:4D1P}.
FT   HELIX       390    392       {ECO:0000244|PDB:4D1P}.
FT   HELIX       394    412       {ECO:0000244|PDB:4D1P}.
FT   HELIX       420    438       {ECO:0000244|PDB:4D1P}.
FT   HELIX       445    448       {ECO:0000244|PDB:4D1P}.
FT   STRAND      451    453       {ECO:0000244|PDB:4D1P}.
FT   HELIX       454    456       {ECO:0000244|PDB:4D1P}.
FT   HELIX       458    461       {ECO:0000244|PDB:4D1P}.
FT   STRAND      470    474       {ECO:0000244|PDB:4D1P}.
FT   HELIX       496    506       {ECO:0000244|PDB:1NIW}.
FT   HELIX       507    509       {ECO:0000244|PDB:1NIW}.
SQ   SEQUENCE   1203 AA;  133289 MW;  CD9E60FA277B22C6 CRC64;
     MGNLKSVAQE PGPPCGLGLG LGLGLCGKQG PATPAPEPSR APASLLPPAP EHSPPSSPLT
     QPPEGPKFPR VKNWEVGSIT YDTLSAQAQQ DGPCTPRRCL GSLVFPRKLQ GRPSPGPPAP
     EQLLSQARDF INQYYSSIKR SGSQAHEQRL QEVEAEVAAT GTYQLRESEL VFGAKQAWRN
     APRCVGRIQW GKLQVFDARD CRSAQEMFTY ICNHIKYATN RGNLRSAITV FPQRCPGRGD
     FRIWNSQLVR YAGYRQQDGS VRGDPANVEI TELCIQHGWT PGNGRFDVLP LLLQAPDEPP
     ELFLLPPELV LEVPLEHPTL EWFAALGLRW YALPAVSNML LEIGGLEFPA APFSGWYMST
     EIGTRNLCDP HRYNILEDVA VCMDLDTRTT SSLWKDKAAV EINVAVLHSY QLAKVTIVDH
     HAATASFMKH LENEQKARGG CPADWAWIVP PISGSLTPVF HQEMVNYFLS PAFRYQPDPW
     KGSAAKGTGI TRKKTFKEVA NAVKISASLM GTVMAKRVKA TILYGSETGR AQSYAQQLGR
     LFRKAFDPRV LCMDEYDVVS LEHETLVLVV TSTFGNGDPP ENGESFAAAL MEMSGPYNSS
     PRPEQHKSYK IRFNSISCSD PLVSSWRRKR KESSNTDSAG ALGTLRFCVF GLGSRAYPHF
     CAFARAVDTR LEELGGERLL QLGQGDELCG QEEAFRGWAQ AAFQAACETF CVGEDAKAAA
     RDIFSPKRSW KRQRYRLSAQ AEGLQLLPGL IHVHRRKMFQ ATIRSVENLQ SSKSTRATIL
     VRLDTGGQEG LQYQPGDHIG VCPPNRPGLV EALLSRVEDP PAPTEPVAVE QLEKGSPGGP
     PPGWVRDPRL PPCTLRQALT FFLDITSPPS PQLLRLLSTL AEEPREQQEL EALSQDPRRY
     EEWKWFRCPT LLEVLEQFPS VALPAPLLLT QLPLLQPRYY SVSSAPSTHP GEIHLTVAVL
     AYRTQDGLGP LHYGVCSTWL SQLKPGDPVP CFIRGAPSFR LPPDPSLPCI LVGPGTGIAP
     FRGFWQERLH DIESKGLQPT PMTLVFGCRC SQLDHLYRDE VQNAQQRGVF GRVLTAFSRE
     PDNPKTYVQD ILRTELAAEV HRVLCLERGH MFVCGDVTMA TNVLQTVQRI LATEGDMELD
     EAGDVIGVLR DQQRYHEDIF GLTLRTQEVT SRIRTQSFSL QERQLRGAVP WAFDPPGSDT
     NSP
//
